Schechter Investment Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$2.31M Sell
22,857
-2,734
-11% -$275K 0.19% 108
2024
Q4
$2.29M Buy
25,591
+758
+3% +$66.7K 0.18% 111
2024
Q3
$2.08M Sell
24,833
-3,786
-13% -$298K 0.15% 128
2024
Q2
$2.2M Buy
28,619
+27
+0.1% +$1.98K 0.17% 106
2024
Q1
$1.96M Sell
28,592
-577
-2% -$37.1K 0.15% 124
2023
Q4
$1.69M Sell
29,169
-2,361
-7% -$126K 0.15% 137
2023
Q3
$1.66M Buy
31,530
+2,091
+7% +$110K 0.16% 129
2023
Q2
$1.59M Buy
29,439
+85
+0.3% +$4.44K 0.14% 151
2023
Q1
$1.47M Buy
29,354
+3,886
+15% +$183K 0.14% 178
2022
Q4
$1.18M Sell
25,468
-92
-0.4% -$3.98K 0.11% 239
2022
Q3
$990K Buy
25,560
+4,381
+21% +$176K 0.1% 281
2022
Q2
$790K Sell
21,179
-5,274
-20% -$215K 0.08% 361
2022
Q1
$1.17M Buy
26,453
+927
+4% +$40.2K 0.11% 250
2021
Q4
$1.08M Buy
+25,526
New +$1.07M 0.1% 274

Other funds holding BSX

Schechter Investment Advisors's BSX Position: Q1 2025 in Review

Schechter Investment Advisors reduced its Boston Scientific (BSX) stake by 11% in Q1 2025, selling an estimated $275K and leaving 22,857 shares worth $2.31M. The position accounts for 0.19% of the portfolio, ranked #108.

Schechter Investment Advisors first reported a position in BSX in Q4 2021 and has held it in 14 quarters since. 1,642 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Schechter Investment Advisors held 22,857 shares of Boston Scientific worth $2.31M as of Q1 2025.
  • Schechter Investment Advisors sold 2,734 Boston Scientific shares in Q1 2025, an estimated $275K.
  • Boston Scientific made up 0.19% of Schechter Investment Advisors's portfolio in Q1 2025, its #108 holding.
  • Schechter Investment Advisors first reported a position in Boston Scientific in Q4 2021 and has held it in 14 quarters since.
  • 1,642 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Schechter Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.